Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: Implications for studying obesity-brain interactions in mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 9, 2013, Pages 1456-1462

  Zhang, Le ^a,b   Dasuri, Kalavathi ^a,b   Fernandez Kim, Sun Ok ^a,b   Bruce Keller, Annadora J ^a,b   Freeman, Linnea R ^a,b   Pepping, Jennifer K ^a,b   Beckett, Tina L ^c   Murphy, M Paul ^c   Keller, Jeffrey N ^a,b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adiposity; Alzheimer's disease; Astrocyte; Diabetes; Inflammation; Microglia

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AMYLOID BETA PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BODY FAT; BODY WEIGHT; BRAIN TISSUE; CONTROLLED STUDY; DIET; DIET INDUCED OBESITY; FEMALE; GLIOSIS; INFLAMMATION; LIPID DIET; MALE; MICROGLIA; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; STRATUM ORIENS; VASCULAR AMYLOIDOSIS; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; ENZYME IMMUNOASSAY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; DIET; DISEASE MODELS, ANIMAL; FEMALE; GLIOSIS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; OBESITY; PLAQUE, AMYLOID; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 84881219156     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.01.002     Document Type: Article

References (86)

1. McCrimmon R.J., Ryan C.M., Frier B.M. Diabetes and cognitive dysfunction. Lancet 2012, 379:2291-2299.
2. Lee E.B. Obesity, leptin, and Alzheimer's disease. Ann. N. Y. Acad. Sci. 2012, 1243:15-29.
3. Anstey K.J., Cherbuin N., Budge M., Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes. Rev. 2011, 12:e426-e437.
4. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch. Neurol. 2009, 66:300-305.
5. Whitmer R.A. The epidemiology of adiposity and dementia. Curr. Alzheimer Res. 2007, 4:117-122.
6. Barton M., Baretella O., Meyer M.R. Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br. J. Pharmacol. 2012, 165:591-602.
7. Béjot Y., Giroud M. Stroke in diabetic patients. Diabetes Metab. 2010, 36(Suppl. 3):S84-S87.
8. Gustafson D.R., Backman K., Waern M., Ostling S., Guo X., Zandi P., Mielke M.M., Bengtsson C., Skoog I. Adiposity indicators and dementia over 32years in Sweden. Neurology 2009, 73:1559-1566.
9. Fitzpatrick A.L., Kuller L.H., Lopez O.L., Diehr P., O'Meara E.S., Longstreth W.T., Luchsinger J.A. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch. Neurol. 2009, 66:336-342.
10. Whitmer R.A., Gustafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008, 71:1057-1064.
11. Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res. 2007, 4:103-109.
12. Chiang C.J., Yip P.K., Wu S.C., Lu C.S., Liou C.W., Liu H.C., Liu C.K., Chu C.H., Hwang C.S., Sung S.F., Hsu Y.D., Chen C.C., Liu S.I., Yan S.H., Fong C.S., Chang S.F., You S.L., Chen C.J. Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan. Am. J. Geriatr. Psychiatry 2007, 15:762-771.
13. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kåreholt I., Winblad B., Helkala E.L., Tuomilehto J., Soininen H., Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 2005, 62:1556-1560.
14. Panchal S.K., Brown L. Rodent models for metabolic syndrome research. J. Biomed. Biotechnol. 2011, 2011:351982.
15. Dubuc P.U. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism 1976, 25:1567-1574.
16. Van den Bergh A., Vanderper A., Vangheluwe P., Desjardins F., Nevelsteen I., Verreth W., Wuytack F., Holvoet P., Flameng W., Balligand J.L., Herijgers P. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc. Res. 2008, 77:371-379.
17. Dobrzyn P., Dobrzyn A., Miyazaki M., Ntambi J.M. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice. J. Lipid Res. 2010, 51:2202-2210.
18. Bigorgne A.E., Bouchet-Delbos L., Naveau S., Dagher I., Prévot S., Durand-Gasselin I., Couderc J., Valet P., Emilie D., Perlemuter G. Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of fatty liver inflammation in obese mice. Gastroenterology 2008, 134:1459-1469.
19. Ae Park S., Choi M.S., Cho S.Y., Seo J.S., Jung U.J., Kim M.J., Sung M.K., Park Y.B., Lee M.K. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 2006, 79:1207-1213.
20. Ge F., Zhou S., Hu C., Lobdell H., Berk P.D. Insulinand leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice. Am. J. Physiol. 2010, 299:G855-G866.
21. Scarda A., Franzin C., Milan G., Sanna M., Dal Prà C., Pagano C., Boldrin L., Piccoli M., Trevellin E., Granzotto M., Gamba P., Federspil G., De Coppi P., Vettor R. Increased adipogenic conversion of muscle satellite cells in obese Zucker rats. Int. J. Obes. 2010, 34:1319-1327.
22. Van den Brom C.E., Huisman M.C., Vlasblom R., Boontje N.M., Duijst S., Lubberink M., Molthoff C.F., Lammertsma A.A., van der Velden J., Boer C., Ouwens D.M., Diamant M. Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc. Diabetol. 2009, 8. (article 39).
23. Serpillon S., Floyd B.C., Gupte R.S., George S., Kozicky M., Neito V., Recchia F., Stanley W., Wolin M.S., Gupte S.A. Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H153-H162.
24. Grabowski T.J., Cho H.S., Vonsattel J.P., Rebeck G.W., Greenberg S.M. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol. 2001, 49:697-705.
25. Kumar-Singh S. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques. Genes Brain Behav. 2008, 7(Suppl. 1):67-82.
26. McCarron M.O., Nicoll J.A., Graham D.I. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors. J. Neurol. Neurosurg. Psychiatry 1998, 65:405-406.
27. Chen H., Zhang J.H. Cerebral amyloid angiopathy-related microhemorrhages in Alzheimer's disease: a review of investigative animal models. Acta Neurochir. Suppl. 2011, 111:15-17.
28. Pezzini A., Del Zotto E., Volonghi I., Giossi A., Costa P., Padovani A. Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. Curr. Med. Chem. 2009, 16:2498-24513.
29. Davis J., Xu F., Deane R., Romanov G., Previti M.L., Vasek M., Davis J., Van Nostrand W.E. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J. Biol. Chem. 2004, 279:20296-20306.
30. Van Nostrand W.E., Xu F., Rozemuller A.J., Colton C.A. Enhanced capillary amyloid angiopathy-associated pathology in Tg-SwDI mice with deleted nitric oxide synthase 2. Stroke 2010, 41:S135-S138.
31. Van Vickle G.D., Esh C.L., Daugs I.D., Kokjohn T.A., Kalback W.M., Patton R.L., Luehrs D.C., Walker D.G., Lue L.F., Beach T.G., Davis J., Van Nostrand W.E., Castaño E.M., Roher A.E. Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy. Am. J. Pathol. 2008, 173:483-493.
32. Hariri N., Thibault L. High-fat diet-induced obesity in animal models. Nutr. Res. Rev. 2010, 23:270-299.
33. Moroz N., Tong M., Longato L., Xu H., de la Monte S.M. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J. Alzheimers Dis. 2008, 15:29-44.
34. Cao D., Lu H., Lewis T.L., Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J. Biol. Dis. 2007, 282:36275-36282.
35. Hiltunen M., Khandelwal V.K., Yaluri N., Tiilikainen T., Tusa M., Koivisto H., Krzisch M., Vepsäläinen S., Mäkinen P., Kemppainen S., Miettinen P., Haapasalo A., Soininen H., Laakso M., Tanila H. Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J. Cell. Mol. Med. 2012, 16:1206-1222.
36. Hommet C., Mondon K., Constans T., Beaufils E., Desmidt T., Camus V., Cottier J.P. Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds. Dement. Geriatr. Cogn. Disord. 2011, 32:367-378.
37. Van Nostrand W.E. Cellular and transgenic animal models of cerebrovascular amyloidosis. Mol. Med. Today 2000, 6:373-374.
38. Zhang L., Ebenezer P.J., Dasuri K., Fernandez-Kim S.O., Francis J., Mariappan N., Gao Z., Ye J., Bruce-Keller A.J., Keller J.N. Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E599-E607.
39. Beckett T.L., Webb R.L., Niedowicz D.M., Holler C.J., Matveev S., Baig I., Levine Iii H., Keller J.N., Murphy M.P. Postmortem Pittsburgh Compound B (PiB) Binding Increases with Alzheimer's Disease Progression. J. Alzheimers Dis. 2012, 32:127-138.
40. Niedowicz D.M., Beckett T.L., Matveev S., Weidner A.M., Baig I., Kryscio R.J., Mendiondo M.S., LeVine H.L., Keller J.N., Murphy M.P. Pittsburgh compound B and the postmortem diagnosis of Alzheimers disease. Ann. Neurol. 2012, 72:564-570.
41. Bruce-Keller A.J., Gupta S., Knight A.G., Beckett T.L., McMullen J.M., Davis P.R., Murphy M.P., Van Eldik L.J., St Clair D., Keller J.N. Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation. Neurobiol. Dis. 2011, 44:317-326.
42. Murphy M.P., Beckett T.L., Ding Q., Patel E., Markesbery W.R., St Clair D.K. H. 3rd LeVine, J.N. Keller, Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiol. Dis. 2007, 27:301-311.
43. Freeman L.R., Zhang L., Dasuri K., Fernandez-Kim S.O., Bruce-Keller A.J., Keller J.N. Mutant Amyloid Precursor Protein Differentially Alters Adipose Biology under Obesogenic and Non-Obesogenic Conditions. PLoS One 2012, 7:e43193.
44. Umeda T., Tomiyama T., Kitajima E., Idomoto T., Nomura S., Lambert M.P., Klein W.L., Mori H. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice. Life Sci. 2012, 91:1169-1176.
45. Thirumangalakudi L., Prakasam A., Zhang R., Bimonte-Nelson H., Sambamurti K., Kindy M.S., Bhat N.R. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J. Neurochem. 2008, 106:475-485.
46. Refolo L.M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., Pappolla M.A. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 2000, 7:321-331.
47. Garber A.J. Obesity and type 2 diabetes: which patients are at risk?. Diabetes Obes. Metab. 2012, 14:399-408.
48. Flegal K.M., Carroll M.D., Ogden C.L., Curtin R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
49. Bays H.E., Chapman R.H., Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int. J. Clin. Pract. 2007, 61:737-747.
50. Vykoukal D., Davies M.G. Vascular biology of metabolic syndrome. J. Vasc. Surg. 2011, 54:819-831.
51. Vykoukal D., Davies M.G. Biology of metabolic syndrome in a vascular patient. Vascular 2012, 20:156-165.
52. Gregory S.M., Headley S.A., Wood R.J. Effects of dietary macronutrient distribution on vascular integrity in obesity and metabolic syndrome. Nutr. Rev. 2011, 69:509-519.
53. Yamada-Goto N., Katsuura G., Ochi Y., Ebihara K., Kusakabe T., Hosoda K., Nakao K. Impairment of fear-conditioning responses and changes of brain neurotrophic factors in diet-induced obese mice. J. Neuroendocrinol. 2012, 24:1120-1125.
54. Maesako M., Uemura K., Kubota M., Kuzuya A., Sasaki K., Hayashida N., Asada-Utsugi M., Watanabe K., Uemura M., Kihara T., Takahashi R., Shimohama S., Kinoshita A. Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J. Biol. Chem. 2012, 287:23024-23033.
55. Puig K.L., Floden A.M., Adhikari R., Golovko M.Y., Combs C.K. Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity. PLoS One 2012, 7:e30378.
56. Mody N., Agouni A., McIlroy G.D., Platt B., Delibegovic M. Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein. Diabetologia 2011, 54:2143-2151.
57. Buckman L.B., Thompson M.M., Moreno H.N., Ellacott K.L. Regional astrogliosis in the mouse hypothalamus in response to obesity. J. Comp. Neurol. 2013, 521:1322-1333.
58. Heyward F.D., Walton R.G., Carle M.S., Coleman M.A., Garvey W.T., Sweatt J.D. Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression. Neurobiol. Learn. Mem. 2012, 98:25-32.
59. Sharma S., Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int. J. Obes. (Lond) 2013, 37:382-389.
60. Finger B.C., Dinan T.G., Cryan J.F. High-fat diet selectively protects against the effects of chronic social stress in the mouse. Neuroscience 2011, 192:351-360.
61. Kozak L.P. Brown fat and the myth of diet-induced thermogenesis. Cell Metab. 2010, 11:263-267.
62. Kozak L.P., Koza R.A., Anunciado-Koza R. Brown fat thermogenesis and body weight regulation in mice: relevance to humans. Int. J. Obes. (Lond) 2010, 34(Suppl. 1):S23-S27.
63. Korach-André M., Archer A., Barros R.P., Parini P., Gustafsson J.Å. Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:403-408.
64. Lee Y.H., Tharp W.G., Maple R.L., Nair S., Permana P.A., Pratley R.E. Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity 2008, 16:1493-1500.
65. Wang J., Ho L., Qin W., Rocher A.B., Seror I., Humala N., Maniar K., Dolios G., Wang R., Hof P.R., Pasinetti G.M. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J. 2005, 19:659-661.
66. Drake C., Boutin H., Jones M.S., Denes A., McColl B.W., Selvarajah J.R., Hulme S., Georgiou R.F., Hinz R., Gerhard A., Vail A., Prenant C., Julyan P., Maroy R., Brown G., Smigova A., Herholz K., Kassiou M., Crossman D., Francis S., Proctor S.D., Russell J.C., Hopkins S.J., Tyrrell P.J., Rothwell N.J., Allan S.M. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav. Immun. 2011, 25:1113-1122.
67. Studzinski C.M., Li F., Bruce-Keller A.J., Fernandez-Kim S.O., Zhang L., Weidner A.M., Markesbery W.R., Murphy M.P., Keller J.N. Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice. J. Neurochem. 2009, 108:860-866.
68. Gupta S., Knight A.G., Gupta S., Keller J.N., Bruce-Keller A.J. Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J. Neurochem. 2012, 120:1060-1071.
69. Bruce-Keller A.J., White C.L., Gupta S., Knight A.G., Pistell P.J., Ingram D.K., Morrison C.D., Keller J.N. NOX activity in brain aging: exacerbation by high fat diet. Free Radic. Biol. Med. 2010, 49:22-30.
70. Pistell P.J., Morrison C.D., Gupta S., Knight A.G., Keller J.N., Ingram D.K., Bruce-Keller A.J. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J. Neuroimmunol. 2010, 219:25-32.
71. Xing C., Hayakawa K., Lok J., Arai K., Lo E.H. Injury and repair in the neurovascular unit. Neurol. Res. 2012, 34:325-330.
72. Willis C.L. Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit. Toxicol. Pathol. 2011, 39:172-185.
73. Lecrux C., Hamel E. The neurovascular unit in brain function and disease. Acta Physiol (Oxf.) 2011, 203:47-59.
74. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005, 28:202-208.
75. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723-738.
76. Huffman D.M., Barzilai N. Contribution of adipose tissue to health span and longevity. Interdiscip. Top. Gerontol. 2010, 37:1-19.
77. Muzumdar R., Allison D.B., Huffman D.M., Ma X., Atzmon G., Einstein F.H., Fishman S., Poduval A.D., McVei T., Keith S.W., Barzilai N. Visceral adipose tissue modulates mammalian longevity. Aging Cell 2008, 7:438-440.
78. Cartwright M.J., Tchkonia T., Kirkland J.L. Aging in adipocytes: potential impact of inherent, depot-specific mechanisms. Exp. Gerontol. 2007, 42:463-471.
79. Jackson T.D., Hutter M.M. Morbidity and effectiveness of laparoscopic sleeve gastrectomy, adjustable gastric band, and gastric bypass for morbid obesity. Adv. Surg. 2012, 46:255-268.
80. Mumphrey M.B., Patterson L.M., Zheng H., Berthoud H.R. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol. Motil. 2013, 25:70-79.
81. Shin A.C., Zheng H., Pistell P.J., Berthoud H.R. Roux-en-Y gastric bypass surgery changes food reward in rats. Int. J. Obes. (Lond) 2011, 35:642-651.
82. Shin A.C., Zheng H., Townsend R.L., Sigalet D.L., Berthoud H.R. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010, 151:1588-1597.
83. Tezapsidis N., Johnston J.M., Smith M.A., Ashford J.W., Casadesus G., Robakis N.K., Wolozin B., Perry G., Zhu X., Greco S.J., Sarkar S. Leptin: a novel therapeutic strategy for Alzheimer's disease. J. Alzheimers Dis. 2009, 16:731-740.
84. Morrison C.D. Leptin signaling in brain: A link between nutrition and cognition?. Biochim. Biophys. Acta 2009, 1792:401-408.
85. Pan W., Hsuchou H., Jayaram B., Khan R.S., Huang E.Y., Wu X., Chen C., Kastin A.J. Leptin action on nonneuronal cells in the CNS: potential clinical applications. Ann. N. Y. Acad. Sci. 2012, 1264:64-71.
86. Takeda S., Sato N., Uchio-Yamada K., Sawada K., Kunieda T., Takeuchi D., Kurinami H., Shinohara M., Rakugi H., Morishita R. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7036-7041.